Skip to main content
. 2016 Apr 28;7(24):36065–36073. doi: 10.18632/oncotarget.9130

Figure 3. Subgroup analysis of the prognostic effect of Tregs.

Figure 3

(A) meta-analysis of high Tregs infiltration and recurrence-free survival in the studies used the tumor tissue; (B) meta-analysis of high Tregs infiltration and overall survival in the studies used the tumor tissue; (C) meta-analysis of high Tregs infiltration and overall survival in the studies used Foxp3+ as the Tregs marker; (D) meta-analysis of high Tregs infiltration and overall survival by same ethnicity.